Vaccine Hesitancy: Implications for Uptake, Public Health, Policy, and Practice

Dear Colleagues,

The World Health Organization has listed vaccine hesitancy, i.e., the delay in uptake or refusal of vaccines regardless of the availability of vaccination services, as one of ten threats to global health. Vaccine hesitancy is a complex, context-specific phenomenon, varying across time, place and vaccines.

We know that factors such as complacency, convenience and confidence influence individuals’ attitudes towards vaccination. The ongoing COVID-19 pandemic has brought vaccine hesitancy to the forefront of public debate. Health inequalities are worsening in many parts of the world, and vaccine hesitancy contributes to this trend. For example, in the United Kingdom, coverage of the measles, mumps and rubella (MMR) vaccine has dropped to significantly below the World Health Organization’s 95% target needed for the elimination of measles, and there are indications that, in the wake of the pandemic, COVID-19 vaccine hesitancy may be affecting routine childhood immunizations.

Vaccine hesitancy tends to be particularly prevalent in underserved communities, such as minority ethnic, and socio-economically deprived groups. Even a small reduction in immunization rates impacts negatively on herd immunity, placing additional burden on healthcare. It is, therefore, critical to identify factors affecting vaccine hesitancy and to develop interventions to address this issue.

In this Special Issue, we will collect original research on vaccine hesitancy across a range of vaccines, populations and settings. We will focus on research that has the potential to inform policy and practice in relation to increasing vaccine uptake.

Prof. Dr. Jonathan Ling
Dr. Judith Eberhardt
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.